These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7685718)

  • 1. Serum levels of insulin-like growth factor binding protein-1 and ovulatory responses to clomiphene citrate in women with polycystic ovarian disease.
    Tiitinen AE; Laatikainen TJ; Seppälä MT
    Fertil Steril; 1993 Jul; 60(1):58-62. PubMed ID: 7685718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.
    Rouzi AA; Ardawi MS
    Fertil Steril; 2006 Feb; 85(2):428-35. PubMed ID: 16595222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome.
    de Leo V; la Marca A; Morgante G; Ciotta L; Mencaglia L; Cianci A; Petraglia F
    Hum Reprod; 2000 Nov; 15(11):2302-5. PubMed ID: 11056123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum insulin in clomiphene responders and nonresponders with polycystic ovarian disease.
    Espinosa de los Monteros A; Ayala J; Sanabria LC; Parra A
    Rev Invest Clin; 1995; 47(5):347-53. PubMed ID: 8584804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.
    Imani B; Eijkemans MJ; de Jong FH; Payne NN; Bouchard P; Giudice LC; Fauser BC
    J Clin Endocrinol Metab; 2000 Feb; 85(2):676-82. PubMed ID: 10690875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease.
    Seyam E; Hasan M; Khalifa EM; Ramadan A; Hefzy E
    Gynecol Endocrinol; 2017 Nov; 33(11):892-898. PubMed ID: 28480767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
    Taskin O; Yalcinoglu AI; Kafkasli A; Burak F; Ozekici U
    Fertil Steril; 1996 Jun; 65(6):1115-8. PubMed ID: 8641482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome.
    Homburg R; Orvieto R; Bar-Hava I; Ben-Rafael Z
    Hum Reprod; 1996 Apr; 11(4):716-9. PubMed ID: 8671313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naloxone on plasma insulin, insulin-like growth factor I, and its binding protein 1 in patients with polycystic ovarian disease.
    Laatikainen T; Anttila L; Suikkari AM; Ruutiainen K; Erkkola R; Seppälä M
    Fertil Steril; 1990 Sep; 54(3):434-7. PubMed ID: 1697813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian electrocauterization causes LH-regulated but not insulin-regulated endocrine changes.
    Tiitinen A; Tenhunen A; Seppälä M
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):181-4. PubMed ID: 7690311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
    Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.
    Abuelghar WM; Bayoumy HA; Ellaithy MI; Khalil MS
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():178-85. PubMed ID: 24576485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome.
    Conway GS; Jacobs HS; Holly JM; Wass JA
    Clin Endocrinol (Oxf); 1990 Nov; 33(5):593-603. PubMed ID: 1701371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
    Mohsen IA
    Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomiphene citrate reduces serum insulin-like growth factor I and increases sex hormone-binding globulin levels in women with polycystic ovary syndrome.
    Bützow TL; Kettel LM; Yen SS
    Fertil Steril; 1995 Jun; 63(6):1200-3. PubMed ID: 7750589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate.
    Murakawa H; Hasegawa I; Kurabayashi T; Tanaka K
    J Reprod Med; 1999 Jan; 44(1):23-7. PubMed ID: 9987735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.